1-(4-(1-(2,6-DIFLUOROBENZYL)-3-(6-METHOXYPYRIDAZIN-3-YL)-5-((METHYL(NITROSO)AMINO)METHYL)-2,4-DIOXO-1,2,3,4-TETRAHYDROTHIENO(2,3-D)PYRIMIDIN-6-YL)PHENYL)-3-METHOXYUREA
UNII RF4PXK9JNV
Substance Identification & Data
This profile provides standardized clinical and technical data for 1-(4-(1-(2,6-difluorobenzyl)-3-(6-methoxypyridazin-3-yl)-5-((methyl(nitroso)amino)methyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno(2,3-d)pyrimidin-6-yl)phenyl)-3-methoxyurea, uniquely identified by the FDA Unique Ingredient Identifier (UNII) RF4PXK9JNV.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C28H24F2N8O6S QLPYCAKOKGXWOC-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 1-(4-(1-(2,6-difluorobenzyl)-3-(6-methoxypyridazin-3-yl)-5-((methyl(nitroso)amino)methyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno(2,3-d)pyrimidin-6-yl)phenyl)-3-methoxyurea. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.